Comparative Pharmacology
Head-to-head clinical analysis: PENICILLIN G POTASSIUM IN PLASTIC CONTAINER versus PYOPEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENICILLIN G POTASSIUM IN PLASTIC CONTAINER versus PYOPEN.
PENICILLIN G POTASSIUM IN PLASTIC CONTAINER vs PYOPEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Penicillin G is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and activating autolytic enzymes.
Carbenicillin is a bactericidal penicillin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking.
2-4 million units IV every 4 hours for moderate to severe infections; up to 24 million units/day for serious infections (meningitis, endocarditis).
4 g intravenously every 4 hours.
None Documented
None Documented
0.5–1 hour (normal renal function). Prolonged in renal impairment (up to 7–10 hours in anuria).
30-60 minutes in normal renal function; prolonged to 2-4 hours in moderate renal impairment (CrCl 10-30 mL/min) and up to 10 hours in severe renal failure.
Renal: 60–90% unchanged via tubular secretion and glomerular filtration. Biliary/fecal: <10%.
Primarily renal (60-90% unchanged via glomerular filtration and tubular secretion); small amounts biliary (10-30%) and fecal (<10%).
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic